About Thymosin Alpha-1
Thymosin Alpha-1 is a 28-amino acid peptide associated with thymic function and widely used in immunology research. Supplied as a lyophilized powder for laboratory studies investigating T-cell signaling pathways, immune response markers, and cytokine-associated mechanisms in controlled experimental systems. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Thymosin α1-induced secretion of the IL-15/RA complex by THP-1-derived dendritic cells restrains HIV latency in vitro.
Recent research on Thymosin Alpha-1: Thymosin α1-induced secretion of the IL-15/RA complex by THP-1-derived dendritic cells restrains HIV latency in vitro.
Read Full Study on PubMedRegarding IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8+ T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.
Recent research on Thymosin Alpha-1: Regarding IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8+ T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.
Read Full Study on PubMedAdditional Studies
Thymosin Alpha-1 Restores Chemotherapy-Induced Antitumor Immunity by Chaperoning a MicroRNA Ligand of TLR7 in Dendritic Cells.
Recent research on Thymosin Alpha-1: Thymosin Alpha-1 Restores Chemotherapy-Induced Antitumor Immunity by Chaperoning a MicroRNA Ligand of TLR7 in Dendritic Cells.
Read on PubMedThymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro.
Recent research on Thymosin Alpha-1: Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro.
Read on PubMedIL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8(+) T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.
Recent research on Thymosin Alpha-1: IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8(+) T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.
Read on PubMedPreliminary results from a phase II trial of spatially fractionated radiotherapy combined with immunotherapy and anti-angiogenic therapy in patients with bulky solid tumors: early evidence of promising efficacy and favorable safety.
Recent research on Thymosin Alpha-1: Preliminary results from a phase II trial of spatially fractionated radiotherapy combined with immunotherapy and anti-angiogenic therapy in patients with bulky solid tumors: early evidence of promisin
Read on PubMedThymosin α1 improves the outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure by restoring immune balance.
Recent research on Thymosin Alpha-1: Thymosin α1 improves the outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure by restoring immune balance.
Read on PubMedPeptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation.
Recent research on Thymosin Alpha-1: Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation.
Read on PubMedRelated Research
Purchase Thymosin Alpha-1 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.